Biophotonic compositions for the treatment of otitis externa
US11154532B2 · kind B2 · utility
0Cited by
18References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2020 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Apr 6, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.